Skip to main content



As a result of the significant disruption that is being caused by the COVID-19 pandemic we are very aware that many researchers will have difficulty in meeting the timelines associated with our peer review process during normal times.  Please do let us know if you need additional time. Our systems will continue to remind you of the original timelines but we intend to be highly flexible at this time.

BMC Series Focus Issue

June: Effect of environment on biology

To celebrate World Environment day, we present this month's focus issue on the effect of environment on biology. Here is a selection of manuscripts from different BMC Series Journals focusing on the influence of local environment at at a cellular and whole organism level.

Featured Article

Back to top

Vaccines © Alpha Stock Images -

A new method for cheaper and longer-lasting vaccines

A recent article published in BMC Biotechnology explores a new method to build longer lasting thermo-stable vaccines for a fraction of the cost. Read the full article here.


Aims and scope

BMC Biotechnology is an open access, peer-reviewed journal that considers articles on the manipulation of biological macromolecules or organisms for use in experimental procedures, cellular and tissue engineering or in the pharmaceutical, agricultural biotechnology and allied industries.

To read the full scope of the journal, click here. 

Read More

BMC Biotechnology is recruiting new Associate Editors

Learn more about the role and requirements here and if interested please complete the accompanying Application form

Read More


Manuscript Editor

Assistant Editor

  • Lauren McMillan, BioMed Central, UK

Section Editors

  • Joaquim M Cabral, Instituto Superior Tecnico
  • Dennis ClaessenLeiden University
  • Peter J PuntTNO Microbiology & Systems Biology/Leiden University
  • Marko RadicUniversity of Tennessee
  • John J Rossi, Beckman Research Institute City of Hope
  • Igor Stagljar, University of Toronto
  • Hyung Joon Cha, Pohang University of Science and Technology
  • Ting Lu, University of Illinois at Urbana-Champaign

Peter Punt

Peter J. Punt, PhD is Chief Technology Officer of Dutch DNA Biotech BV, a fungal biotechnology technology provider and contract research company situated in the Netherlands. In 2008 he was appointed at Leiden University in the chair of Industrial Biotechnology He joined BMC Biotechnology as a  Section Editor in 2012.

Latest Tweets